CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 106 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2019. The put-call ratio across all filers is 1.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $281,000 | -71.2% | 57,687 | -59.0% | 0.00% | -100.0% |
| Q2 2019 | $976,000 | -1.4% | 140,783 | -1.2% | 0.00% | 0.0% |
| Q1 2019 | $990,000 | +18.4% | 142,496 | -0.5% | 0.00% | 0.0% |
| Q4 2018 | $836,000 | -25.6% | 143,210 | -3.8% | 0.00% | 0.0% |
| Q3 2018 | $1,124,000 | +62.7% | 148,868 | +8.8% | 0.00% | 0.0% |
| Q2 2018 | $691,000 | -17.7% | 136,802 | -0.6% | 0.00% | 0.0% |
| Q1 2018 | $840,000 | -0.5% | 137,624 | +15.8% | 0.00% | 0.0% |
| Q4 2017 | $844,000 | -2.0% | 118,846 | -1.3% | 0.00% | 0.0% |
| Q3 2017 | $861,000 | +13.1% | 120,454 | -0.2% | 0.00% | 0.0% |
| Q2 2017 | $761,000 | +0.7% | 120,720 | +31.7% | 0.00% | 0.0% |
| Q1 2017 | $756,000 | – | 91,680 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 397,168 | $43,888 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $3,366 | 0.00% |
| Tekla Capital Management LLC | 154,310 | $17,051 | 0.00% |
| McAdam, LLC | 10,006 | $6 | 0.00% |
| Aries Wealth Management | 15,400 | $1,702 | 0.00% |
| WELLS FARGO & COMPANY/MN | 342,084 | $37,800 | 0.00% |
| JPMORGAN CHASE & CO | 43,415 | $5 | 0.00% |
| NORTHERN TRUST CORP | 207,329 | $22,910 | 0.00% |
| PINNACLE ASSOCIATES LTD | 18,580 | $2,053 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |